Stocks to buy

Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth.  The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in

Sofi Technologies (NASDAQ:SOFI) reported good Q2 results on Aug. 12, including record quarterly growth of 101% year-over-year (YoY) and adj. revenue up 74%. The problem is, as I wrote last month, SOFI stock looks to be fairly valued now. That seems to imply that the stock might not rise. Or could it? This article will

Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and

Opendoor (NASDAQ:OPEN), the digital platform for residential real estate, is still quite undervalued even though OPEN stock is up a good deal. As I predicted in my article back in July, the company’s massive buying spree — along with rising real estate market prices — has led to positive profits. Source: Shutterstock OPEN stock has actually

Production Preview Week 1 is on deck for Lucid Motors (NASDAQ:LCID), and people are taking notice. After all, this is a literal door-opening event, and LCID stock is up a few percent today alone. And there’s still more to come. Source: Around the World Photos / Shutterstock.com Long story short, Lucid Motors has long claimed

Electric vehicle charging infrastructure company ChargePoint (NYSE:CHPT) reported much better-than-expected Q2 sales in early September. While CHPT stock initially popped following the announcement, shares now sit about 3% lower than before the report. What gives? Source: Michael Vi / Shutterstock.com Yes, the company reported a larger-than-expected loss for the quarter. But anyone who’s focused on

Editor’s Note: This article is part of Joanna’s Top Trades — a weekly feature dedicated toward making you money within a specific space. Joanna’s pick for this week is Zoom (NASDAQ:ZM) as the top stock to trade this week. We all know video-calling software maker Zoom (NASDAQ:ZM). The pandemic high-flier capitalized on a stay-at-home workforce, growing

What an interesting week in the markets, huh? Things started off ugly. On Monday, stocks plunged. On Tuesday, they tried to bounce back, but failed. On Wednesday, they did bounce back – and the big gains kept flowing into the end of the week. Source: Shutterstock Source: Shutterstock Why all the volatility? The Fed. Long

On May 28, I wrote that Snowflake, the cloud-based data software platform company, had changed my mind. I forecast a higher value for SNOW stock. I projected that it would hit $300 based on my free cash flow (FCF) estimates and FCF yield metrics. Source: rblfmr / Shutterstock.com SNOW stock closed on Sept. 23 at

Addressing climate change has been a top priority since day one for the Biden administration. Their longer-term agenda being to halve the U.S. carbon footprint by 2030. This sent a lot of “clean-energy” stocks skyrocketing in the early part of the year. One is Clean Energy Fuels (NASDAQ:CLNE) stock. Source: ZikG / Shutterstock.com After trading

The Evergrande crisis seems like China’s Lehmann moment. The markets have been jittery and it remains to be seen if there is a larger spill-over. Amidst this concern, the markets continue to provide investing and speculative opportunities. If I had to focus on buying large-caps, I would look at low-beta stocks. These stocks would protect

Right now, you can say that Sundial Growers (NASDAQ:SNDL) is low-priced, but not cheap. In other words, shares are overvalued at 70 cents per share. Despite the fact the stock has fallen more than 82% off of its meme stock high set in February. Source: Postmodern Studio / Shutterstock.com The reason? Largely, the company’s heavily-dilutive

Given the powerful demand for semiconductors and the steps that Intel (NASDAQ:INTC) is taking to strengthen its supply chain, the medium-term and long-term outlook of INTC stock appears to be strong. Source: Shutterstock Under the leadership of its new CEO,  the tech company appears to be improving the quality of its manufacturing process. Furthermore, the

When you type “oversold stocks to buy” in your search bar, you get millions of results. One could argue that since the S&P 500 hit an all-time high in early September, there aren’t many stocks that qualify for this screen. However, with the financial woes of China Evergrande Group (OTCMKTS:EGRNF) knocking the global markets for

Market sentiment has once again soured on Canadian marijuana producers like Canopy Growth (NASDAQ:CGC). The past few years of poor results are still fresh in the minds of investors. This can be clearly seen in CGC stock, which rallied to a high of more than $50 from late last year to February. Source: Shutterstock Canopy Growth

Commodity prices keep rising amid various supply chain disruptions. That’s causing panic buying of raw materials. As a result, many commodity stocks have reported strong numbers in their recent earnings reports, and banking analysts seem to think that inflationary prices will continue to drive earnings higher. I’d argue that there’s an added dynamic to many

Cybersecurity technology company CrowdStrike (NASDAQ:CRWD) has given investors plenty to cheer about lately. CRWD stock has risen nearly 30% so far in 2021 and 78% over the past year.  Source: Shutterstock That kind of growth has led many investors to question whether a slowdown is imminent. The good news is that it doesn’t appear to

The markets are far from efficient right now, with several undervalued stocks that boast historically-stable cash flows, scandal-free operations, and a robust profitability profile, relegated to the background. Most of the column inches and headlines are reserved for hyper-growth stocks and exciting recovery plays. Post-pandemic, the outlook for several exceptional stocks remains pessimistic because of

At the end of last year, I wrote that analysts’ earnings projections for Moderna (NASDAQ:MRNA) were $9.46 per share for 2021. Now those same analysts have average earnings per share (EPS) forecasts of $30.12 for 2021, or over 3 times the prior numbers. I wrote that MRNA stock was worth $180. But as of Friday,

I bet many readers are scanning through screeners and news articles trying to find out what the future holds for DraftKings (NASDAQ:DKNG) stock. Well, I’d like you all to remember that if you have a long enough investment horizon, the short-term noise in DKNG stock — or any stock — won’t matter. If you analyze